神经导航辅助内镜治疗高血压脑出血的疗效对比分析

目的 分析对比神经导航辅助内镜与传统开颅手术治疗高血压脑出血疗效,探讨其临床应用及价值.方法 收集自2012年1月-2015年11月应用神经导航辅助内镜手术治疗的患者,随机抽取30例为试验组;收集开颅手术治疗高血压脑出血的患者,随机抽取30例为对照组.记录两组患者术后GCS评分,皮肤切口长度、手术时间、手术出血量、住院时间、术后并发症及术后随访第6个月KPS评分进行比较分析.结果 试验组与对照组相比,术后GCS昏迷评分两组差异无统计学意义(P＞0.05);在皮肤切口上,试验组平均切口长度为(4.25 ±0.44) cm,对照组平均切口长度为(13.27±1.01)cm,两组差异有统计学意义(P＜0.05);在手术时间上,试验组平均手术时间为(93.93±21.04) min,对照组的平均手术时间为(176.50 ±35.65) min,两组差异有统计学意义(P＜0.05);在手术出血量上,试验组平均出血量为(69.83 ±23.83) ml,对照组平均出血量为(196.17±33.83) ml,两组对比差异有统计学意义(P＜0.05);在住院天数上,试验组平均住院天数为(13.33 ±1.79)d,对照组的平均住院天数为(16.20±4.31)d,两组对比差异有统计学意义(P＜0.05);在并发症上,试验组发病率明显低于对照组,两组对比差异有统计学意义(P＜0.05);术后随访6个月KPS评分试验组预后优于对照组,两组对比差异有统计学意义(P＜0.05).结论 神经导航辅助内镜治疗高血压脑出血定位准确、微创、直视、省时、止血充分,出血量少,可缩短住院天数、降低并发症发病率,术后恢复好.

Comparative analysis of the efficacy of neural navigation assisted endoscopic treatment for hypertensive cerebral hemorrhage

Objective To explore the clinical application and value of endoscopic surgery in the treatment of hypertensive cerebral hemorrhage assisted with neuronavigation,we compared it with traditional craniotomy.Methods We collected hypertensive cerebral hemorrhage patients with the application of neuronavigation assisted endoscopic surgery from January 2012 to November 2015,and randomly selected 30 cases as experimental group;and collected hypertensive cerebral hemorrhage patients with craniotomy and then randomly selected 30 cases as the control group.What did we respectively record about the two groups were postoperative GCS score,skin incision length,operation time,bleeding volume,length of stay,postoperative complications,and KPS score of the postoperative follow-up of sixth months;after that,the dates of the two groups were compared and analyzed.Results Compared the experimental group to the control group,postoperative GCS score did not achieve statistically significant difference (P ＞ 0.05);in the skin incision,there was statistically significant difference between two groups (P ＜ 0.05),the average incision length in the experimental group was (4.25 ±0.44) cm,however it was (13.27 ± 1.01) cm in the control group;as for the operation time,it was averagely (93.93 ±21.04) min for the experimental group,and (176.50 ± 35.65) min for the control group,there was statistical difference between two groups (P ＜0.05);with regard to the amount of intraoperative bleeding,the mean amount in the experimental group was (69.83 ± 23.83) ml,and (196.17 ± 33.83) ml in the control group,the difference was statistically significant (P ＜ 0.05);and the average hospitalization days for the test group was (13.33 ± 1.79) d,(16.20 ± 4.31) d for the control group,it was considered statistically significant (P ＜ 0.05);in complications,the test group incidence was significantly lower than that in the control group,the difference between the two groups has statistical significance (P ＜ 0.05);after postoperative follow-up of 6 months,we found that the prognosis of experimental group is better than that of control group,and statistical significance was described by analyzing the KPS scores of two groups (P ＜ 0.05).Conclusions Neuronavigation assisted endoscopic technique in the treatment of hypertensive cerebral hemorrhage has many advantages,such as accurate localization,direct vision,perfect hemostasis,and less bleeding.It is minimally invasive and can also shorten the operation time as well as lengths of stay.Besides,it can reduce the incidence of complications and bring better postoperative recovery.